Editorial introductions Less Current Opinion in Lipidology. 19(6):vii-viii, December 2008. Favorite PDF Permissions Free
Effects of ubiquinone (coenzyme Q10) on myopathy in statin users Schaars, Carel F; Stalenhoef, Anton FH Schaars, Carel F; Stalenhoef, Anton FH Less Current Opinion in Lipidology. 19(6):553-557, December 2008. Abstract Abstract Favorite PDF Permissions Buy
Safety of statins Brown, William Virgil Brown, William Virgil Less Current Opinion in Lipidology. 19(6):558-562, December 2008. Abstract Abstract Favorite PDF Permissions Buy
Novel antecedent plasma biomarkers of cardiovascular disease: improved evaluation methods and comparator benchmarks raise the bar Welsh, Paul; Packard, Chris J; Sattar, Naveed Welsh, Paul; Packard, Chris J; Sattar, Naveed Less Current Opinion in Lipidology. 19(6):563-571, December 2008. Abstract Abstract Favorite PDF Permissions Buy
New approaches to target microsomal triglyceride transfer protein Hussain, Mohammed Mahmood; Bakillah, Ahmed Hussain, Mohammed Mahmood; Bakillah, Ahmed Less Current Opinion in Lipidology. 19(6):572-578, December 2008. Abstract Abstract Favorite PDF Permissions Buy
Lipid lowering in diabetes mellitus Betteridge, D John Betteridge, D John Less Current Opinion in Lipidology. 19(6):579-584, December 2008. Abstract Abstract Favorite PDF Permissions Buy
Lipid lowering in the patients with prediabetes/metabolic syndrome: what is the evidence? Steiner, George Steiner, George Less Current Opinion in Lipidology. 19(6):585-591, December 2008. Abstract Abstract Favorite PDF Permissions Buy
The trials and tribulations of the treatment of nonalcoholic fatty-liver disease Gan, Seng Khee; Adams, Leon A; Watts, Gerald F Gan, Seng Khee; Adams, Leon A; Watts, Gerald F Less Current Opinion in Lipidology. 19(6):592-599, December 2008. Abstract Abstract Favorite PDF Permissions Buy
Current World Literature Less Current Opinion in Lipidology. 19(6):600-614, December 2008. Favorite PDF Permissions Buy
Nutrition and metabolism: new insights into lifestyle modifications and pharmacotherapy for managing cardiometabolic risk Ooi, Esther MM; Watts, Gerald F Ooi, Esther MM; Watts, Gerald F Less Current Opinion in Lipidology. 19(6):617-619, December 2008. Favorite PDF Permissions Buy
Lipid metabolism: sphingolipids- from membrane constituents to signaling molecules that control cell-to-cell communications Pétremand, Jannick; Widmann, Christian Pétremand, Jannick; Widmann, Christian Less Current Opinion in Lipidology. 19(6):620-621, December 2008. Favorite PDF Permissions Buy
Lipid metabolism: why is apoM an apolipoprotein? Nielsen, Lars Bo; Dahlbäck, Björn Nielsen, Lars Bo; Dahlbäck, Björn Less Current Opinion in Lipidology. 19(6):622-623, December 2008. Favorite PDF Permissions Buy
Hyperlipidaemia and cardiovascular disease: apolipoprotein measurements and metabolic syndrome as predictors of cardiovascular risk Deans, Kevin A; Dominiczak, Marek H Deans, Kevin A; Dominiczak, Marek H Less Current Opinion in Lipidology. 19(6):624-626, December 2008. Favorite PDF Permissions Buy
Atherosclerosis: cell biology and lipoproteins - shear stress and inflammation in plaque formation: new evidence Segers, Dolf; Weinberg, Peter; Krams, Rob Segers, Dolf; Weinberg, Peter; Krams, Rob Less Current Opinion in Lipidology. 19(6):627-628, December 2008. Favorite PDF Permissions Buy
Therapy and clinical trials: glycaemia and prevention of macroangiopathy in type 2 diabetes Bolusani, Hemanth; Peter, R; Rees, A Bolusani, Hemanth; Peter, R; Rees, A Less Current Opinion in Lipidology. 19(6):629-630, December 2008. Favorite PDF Permissions Buy
Unstable coronary plaques and cardiac events in myocardial infarction-prone Watanabe heritable hyperlipidemic rabbits: questions and quandaries Shiomi, Masashi; Fan, Jianglin Shiomi, Masashi; Fan, Jianglin Less Current Opinion in Lipidology. 19(6):631-636, December 2008. Abstract Abstract Favorite PDF Permissions Buy
